DE SARRO, GIOVAMBATTISTA
 Distribuzione geografica
Continente #
NA - Nord America 16.095
AS - Asia 10.175
EU - Europa 4.789
SA - Sud America 2.089
AF - Africa 274
OC - Oceania 102
Continente sconosciuto - Info sul continente non disponibili 26
AN - Antartide 2
Totale 33.552
Nazione #
US - Stati Uniti d'America 15.342
SG - Singapore 4.312
CN - Cina 2.306
IT - Italia 1.957
BR - Brasile 1.611
IN - India 993
VN - Vietnam 955
GB - Regno Unito 652
DE - Germania 617
CA - Canada 546
SE - Svezia 441
BD - Bangladesh 405
HK - Hong Kong 377
FI - Finlandia 286
AR - Argentina 163
FR - Francia 142
MX - Messico 137
NL - Olanda 128
ID - Indonesia 118
AU - Australia 92
JP - Giappone 92
RU - Federazione Russa 84
ZA - Sudafrica 83
EC - Ecuador 82
CO - Colombia 72
PK - Pakistan 72
IQ - Iraq 70
AE - Emirati Arabi Uniti 64
ES - Italia 64
TR - Turchia 62
CL - Cile 61
UA - Ucraina 57
RO - Romania 54
EG - Egitto 49
PL - Polonia 47
UZ - Uzbekistan 44
KR - Corea 37
SA - Arabia Saudita 36
IR - Iran 33
VE - Venezuela 30
CZ - Repubblica Ceca 29
MA - Marocco 28
PY - Paraguay 28
PH - Filippine 27
MY - Malesia 25
IL - Israele 24
PE - Perù 24
AT - Austria 23
CH - Svizzera 23
IE - Irlanda 23
TN - Tunisia 20
GR - Grecia 18
PT - Portogallo 18
EU - Europa 17
KE - Kenya 16
TW - Taiwan 16
DO - Repubblica Dominicana 15
EE - Estonia 14
JO - Giordania 14
NP - Nepal 14
UY - Uruguay 14
LT - Lituania 13
NO - Norvegia 12
RS - Serbia 12
HN - Honduras 11
SK - Slovacchia (Repubblica Slovacca) 11
JM - Giamaica 10
AZ - Azerbaigian 9
KZ - Kazakistan 9
NZ - Nuova Zelanda 9
TH - Thailandia 9
A2 - ???statistics.table.value.countryCode.A2??? 8
AL - Albania 8
DZ - Algeria 8
KW - Kuwait 8
MD - Moldavia 8
NG - Nigeria 8
SC - Seychelles 8
BE - Belgio 7
HR - Croazia 7
MT - Malta 7
AO - Angola 6
CR - Costa Rica 6
SN - Senegal 6
SY - Repubblica araba siriana 6
BG - Bulgaria 5
CI - Costa d'Avorio 5
ET - Etiopia 5
LB - Libano 5
LK - Sri Lanka 5
NI - Nicaragua 5
TT - Trinidad e Tobago 5
UG - Uganda 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BO - Bolivia 4
CY - Cipro 4
GH - Ghana 4
GT - Guatemala 4
SI - Slovenia 4
Totale 33.477
Città #
San Jose 2.507
Dallas 2.025
Singapore 1.744
Chandler 1.671
Ashburn 1.148
Santa Clara 731
Milan 618
Bengaluru 616
Hefei 596
Princeton 531
Lawrence 519
Munich 475
Chicago 398
Shenzhen 397
London 396
Beijing 368
Ho Chi Minh City 354
Hong Kong 347
Ottawa 339
Wilmington 317
Des Moines 185
Hanoi 185
Catanzaro 183
New York 182
São Paulo 166
Los Angeles 162
Helsinki 138
Boardman 128
Turku 126
Brooklyn 83
Redwood City 82
The Dalles 75
Rome 71
Tokyo 71
Council Bluffs 67
Columbus 59
Mexico City 56
Rio de Janeiro 55
Norwalk 52
Shanghai 52
Haiphong 51
Palermo 51
Pune 49
Amsterdam 47
Montreal 47
Johannesburg 45
Orem 45
Boston 44
Da Nang 44
Chennai 43
Naples 43
Toronto 42
San Francisco 41
Tashkent 40
Guangzhou 39
Buffalo 38
Curitiba 38
Atlanta 35
Jakarta 35
Guayaquil 34
Redmond 34
Phoenix 31
Seattle 31
Melbourne 30
Porto Alegre 30
Warsaw 30
Hải Dương 29
Brasília 28
Santiago 28
West Jordan 28
Belo Horizonte 27
Florence 27
Stockholm 27
Campinas 26
Falls Church 26
Biên Hòa 25
Buenos Aires 25
Bogotá 24
Catania 24
Hyderabad 24
Istanbul 23
Mumbai 23
Charlotte 22
Manchester 22
Messina 22
San Nicola Manfredi 22
Augusta 21
Padova 21
Thái Bình 21
Bari 20
Houston 20
Dhaka 19
Olomouc 19
Quito 19
Baghdad 18
Sydney 18
Bologna 17
Delhi 17
New Delhi 17
Aversa 16
Totale 20.077
Nome #
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 624
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 519
1-Aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents 489
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study 431
Adherence to therapy and adverse drug reactions: is there a link? 300
Adverse effects of atypical antipsychotics in the elderly: a review 293
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 259
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 248
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 184
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 182
Sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities 175
Neuropharmacology of depression in aging and age-related diseases 173
A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations 166
Genetics of reflex seizures and epilepsies in humans and animals 161
Conventional and new antidepressant drugs in the elderly 156
A POSSIBLE DRUG-FOOD INTERACTION INDUCED GENERALISED URTICARIA IN A YOUNG WOMAN 151
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 148
High Prevalence of Achilles Tendon Enthesopathic Changes in Patients with Type 2 Diabetes Without Peripheral Neuropathy 142
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 140
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 136
Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice 131
Transient Receptor Potential Ankyrin 1 (TRPA1) mediates hydrogen sulfide-induced Ca2+ entry and nitric oxide production in human cerebrovascular endothelium. 130
Venlafaxine-Propafenone interaction resulting in hallucinations and psychomotor agitation 127
Conventional and atypical antipsychotics in the elderly - A review 127
25-Hydroxy Vitamin D Detection Using Different Analytic Methods in Patients with Migraine 124
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 123
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 122
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 120
Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats 114
Chlorpromazine versus sleep deprivation in activation of EEG in adult-onset partial epilepsy. 114
Efficacy and safety of bevacizumab in glioblastomas 113
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice 111
Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 110
Uno strano caso di deterioramento cognitivo: quando le interazioni farmaco-alimenti diventano fondamentali. 108
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 107
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 106
Amino acid levels in some lethargic mouse brain areas before and after pentylenetetrazole kindling 105
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 103
Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice 101
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 99
A review on antiepileptic drugs-dependent fatigue: Pathophysiological mechanisms and incidence 95
Neuroactive steroids and GABA(A) receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy 95
Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice 93
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 91
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy 89
Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP 88
Adverse reactions to fluoroquinolones. An overview on mechanistic aspects 88
A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment 88
Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 88
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 88
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention 87
QUINOLONES POTENTIATE CEFAZOLIN-INDUCED SEIZURES IN DBA/2 MICE 86
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 86
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 86
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 86
9-cis Retinoic acid modulates myotrophin expression and its miR in physiological and pathophysiological cell models 85
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 85
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 85
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 84
Melaena following use of the cholinesterase inhibitor rivastigmine 84
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 83
Determination of a potent non-competitive AMPA receptor antagonist in rat brain 82
Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice 82
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report 81
Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice 81
Influence of D-cycloserine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice 80
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 80
3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents 80
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 80
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 79
Apomorphine-induced neurodegeneration in Mongolian gerbil hippocampus 78
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 78
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 78
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 78
A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman 77
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 77
Vitamin D Serum Levels in Subjects Tested for SARS-CoV-2: What Are the Differences among Acute, Healed, and Negative COVID-19 Patients? A Multicenter Real-Practice Study 76
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 75
Data recorded in real life support the safety of nattokinase in patients with vascular diseases 75
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 74
Lithium in late-life mania: a systematic review 74
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 73
7-nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 73
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 73
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 73
Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes 73
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 72
A fatal case of triple whammy in an elderly patient 72
A case of adverse drug reaction induced by dispensing error 72
Adverse drug reactions related to drug administration in hospitalized patients. 72
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 72
Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents 71
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 71
Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient 71
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 70
C-Kit receptor and tryptase expressing mast cells correlate with angiogenesis in breast cancer patients 70
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 70
Asterixis as initial manifestation of cerebellar ischemic stroke 70
Anti TNF.alpha biologic agents and insulin resistence in rheumatoid arthritis: A systematic review and Meta-analysis. Journal of Biological Regulators & Homeostatic Agents 70
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 70
Totale 12.135
Categoria #
all - tutte 292.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 292.493


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/20221.556 5 15 23 420 52 40 24 338 197 187 234 21
2022/20234.748 1.094 216 92 447 480 427 35 371 779 331 365 111
2023/20242.877 475 292 588 157 136 543 116 119 44 122 106 179
2024/20257.094 962 344 370 306 477 907 450 294 848 360 669 1.107
2025/202616.470 698 1.700 2.667 2.490 1.579 566 2.027 856 1.684 1.077 767 359
Totale 34.079